Prevalence of PER and VEB type extended spectrum betalactamases among multidrug resistant Acinetobacter baumannii isolates in North-West of Iran

Iranian Journal of Basic Medical Sciences

Volumn 16, Issue 6, 2013, Pages 751-755

  Farajnia, Safar ^a,b   Azhari, Fatemeh ^b   Alikhani, Mohammad Yousef ^c   Hosseini, Mohammad Kazem ^d   Peymani, Amir ^e   Sohrabi, Nasrolah ^f  

^a UNIVERSITY OF TABRIZ   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISTANBUL UNIVERSITY   (Turkey)

^e QAZVIN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acinetobacter baumannii; Extended spectrum betalactamases; Integron class I

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CARBENICILLIN; CEFALEXIN; CEFALOTIN; CEFIXIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; KANAMYCIN; NORFLOXACIN; OFLOXACIN; PER 1; PER 2; POLYMYXIN B; RIFAMPICIN; TETRACYCLINE; TICARCILLIN; TOBRAMYCIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VEB 1;

ACINETOBACTER BAUMANNII; ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CONTROLLED STUDY; DISK DIFFUSION; DNA EXTRACTION; HUMAN; INTEGRON; IRAN; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE;

EID: 84880274933     PISSN: 20083866     EISSN: 20083874     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Murray PR, Baron EJ, Pfaller MA, Tenover FC,Yolken RH. Manual of Clinical Microbiology.7th e d. Washington,D.C: ASM Press;1999.p. 517- 525.
2. Huang LY, Chen TL, Lu PL, Tsai CA, Cho WL, Chang FY, et al. Dissemination of multidrug-resistant, class 1 integron-carrying Acinetobacter baumannii isolates in Taiwan. Clin Microbiol Infect 2008; 14:1010-1019.
3. Nowak-Zaleska A, Krawczyk B, Kotłowski R, Mikucka A, Gospodarek E. Amplification of a single-locus variable-number direct repeats with restriction fragment length polymorphism (DR-PCR/RFLP) for genetic typing of Acinetobacter baumannii strains. Pol J Microbiol 2008; 57:11-17.
4. Peleg AY, Seifert H, Paterson DL. Successful Pathogen Acinetobacter baumannii: Emergence of a10.1128/CMR00058-07. Clin Microbiol Rev 2008; 21:538.
5. Marais E, G de Jong, Ferraz V, Maloba B, Duse AG. Interhospital transfer of pan-resistant Acinetobacter strains in Johannesburg,South Africa. Am J Infect Control 2004; 32:278-281.
6. Merkier AK, Catalano M, Ramírez MS, Quiroga C, Orman B, Ratier L, et al. Polyclonal spread of blaOXA-23 and blaOXA-58 in Acinetobacter baumannii isolates from Argentina. J Infect Dev Ctries 2008; 2:235-240.
7. Coelho J, Woodford N, Afzal-Shah M, Livermore D. Occurrence of OXA-58-Like Carbapenemases in Acinetobacter spp. collected over 10 years in three continents. Antimicrob Agents Chemother 2006; 50:756-758.
8. Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 2007; 5:939-951.
9. Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14:933-951.
10. Jacoby GA, Munoz-Price LS. Mechanisms of disease the new ß-Lactamases. N Engl J Med 2005; 352:380-391.
11. Gniadkowski M. Evolution and epidemiology of extended-spectrum b-lactamases (ESBLs) and ESBL-producing microorganisms. Clin Microbiol Infect 2001; 7:597-608.
12. Bush K. New beta-lactamases in gram negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin Infect Dis 2001; 32:1085-1089.
13. Stürenburg E, Mack D. Extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. J Infect 2003; 47:273-295.
14. Rasheed JK, Jay C, Metchock B, Berkowitz F, Weigel L, Crellin J, et al. Evolution of extended-spectrum b-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia. Antimicrob Agents Chemother 1997; 41: 647- 653.
15. Ribera A, Vila J, Fernández-Cuenca F, Martínez-Martínez L, Pascual A, Beceiro A, et al. Spanish Group for Nosocomial Infection (GEIH). Type 1 integrons in epidemiologically unrelated acinetobacter baumannii isolates collected at spanish hospitals, American Society for Microbiology. Antimicrob Agents Chemother 2004; 48:364-365.
16. Yousefi S, Farajnia S, Nahaei MR, Akhi MT, Ghotaslou R, Soroush MH, et al. Detection of metallo-β-lactamase-encoding genes among clinical isolates of Pseudomonas aeruginosa in northwest of Iran. Diagn Microbiol Infect Dis 2010; 68:322-325.
17. García-Garmendia JL, Carlos OL, José GM, Francisco-Javier J-J, Carmen P-P, Ana EBA, et al. Risk Factors for Acinetobacter baumannii Nosocomial Bacteremia in Critically Ill Patients:A Cohort Study. Clin Infect Dis 2001; 33: 939-946.
18. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PhN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2007; 51:3471-3484.
19. Vahaboglu H, Oztürk R, Aygün G, Coşkunkan F, Yaman A, Kaygusuz A, et al. Wide- spread detection of PER-1-type extended-spectrum beta-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: A nationwide multi-center study. Antimicrob Agents Chemother 1997; 41:2265-2269.
20. Yong D, Shin JH, Kim S, Lim Y, Yum JH, Lee K, et al. High prevalence of PER-1 extended-spectrum beta-lactamase-producing Acinetobacter spp. in Korea. Antimicrob Agents Chemother 2003; 47:1749-1751.
21. Poirel L, Menuteau O, Agoli N, Cattoen C, Nordmann P. Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of acinetobacter baumannii in a French Hospital. J Clin Microbiol 2003; 41:3542-3547.
22. Naas T, Bogaerts P, Bauraing C, Degheldre Y, Glupczynski Y, Nordmann P. Emergence of PER and VEB extended-spectrum beta-lactamases in Acinetobacter baumannii in Belgium. J Antimicrob Chemother 2006; 58:178-182.
23. Pasterán F, Rapoport M, Petroni A, Faccone D, Corso A, Galas M, et al. Emergence of PER-2 and VEB-1a in Acinetobacter baumannii Strains in the Americas. Antimicrob Agents Chemother 2006; 50:3222-3224.
24. Poirel L, Corvec S, Rapoport M, Mugnier P, Petroni A, Pasteran F, et al. Identification of the novel narrow-spectrum ß-lactamase SCO-1 in Acinetobacter spp. from Argentina. Antimicrob Agents Chemother 2007; 51:2179-2184.
25. Gombac F, Riccio ML, Rossolini GM, Lagatolla C, Tonin E, Monti-Bragadin C, et al. Molecular characterization of integrons in epidemiologically unrelated clinical isolates of acinetobacter baumannii from Italian hospitals reveals a limited diversity of gene cassette arrays. Antimicrob Agents Chemother 2002; 46:3665-3668.
26. Fournier PE, Richet H. The epidemiology and control of Acine to bacter baumannii in health care facilities. Clin Infect Dis 2006; 42:692-699.